VR Adviser, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$1.3T
Holdings
31
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $368.9B | 27.64% | |
| 2 | OCULOCULAR THERAPEUTIX INC | 12,762,462 | $118.4B | 8.88% | |
| 3 | MTSRMETSERA INC | 3,750,662 | $106.7B | 8.00% | |
| 4 | ELVNENLIVEN THERAPEUTICS INC | 4,026,331 | $80.8B | 6.05% | |
| 5 | KALVKALVISTA PHARMACEUTICALS INC | 6,728,985 | $76.1B | 5.70% | |
| 6 | ORICORIC PHARMACEUTICALS INC | 6,596,885 | $67.0B | 5.02% | |
| 7 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,709 | $54.3B | 4.07% | |
| 8 | ORKAORUKA THERAPEUTICS INC | 4,148,428 | $46.5B | 3.48% | |
| 9 | SYRESPYRE THERAPEUTICS INC | 2,685,448 | $40.2B | 3.01% | |
| 10 | PHVSPHARVARIS N V | 2,047,620 | $36.0B | 2.70% | |
| 11 | COGTCOGENT BIOSCIENCES INC | 4,755,411 | $34.1B | 2.56% | |
| 12 | JBIOJADE BIOSCIENCES INC | 3,220,364 | $32.2B | 2.41% | |
| 13 | CTMXCYTOMX THERAPEUTICS INC | 13,969,882 | $31.7B | 2.38% | |
| 14 | CDTXCIDARA THERAPEUTICS INC | 639,088 | $31.1B | 2.33% | |
| 15 | UPBUPSTREAM BIO INC | 2,295,319 | $25.2B | 1.89% | |
| 16 | ERASERASCA INC | 17,857,083 | $22.7B | 1.70% | |
| 17 | CBIOCRESCENT BIOPHARMA INC. | 1,387,864 | $22.4B | 1.68% | |
| 18 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $20.7B | 1.55% | |
| 19 | YB4PSAVARA INC | 8,884,263 | $20.3B | 1.52% | |
| 20 | DNTHDIANTHUS THERAPEUTICS INC | 1,000,000 | $18.6B | 1.40% | |
| 21 | ENGNENGENE HOLDINGS INC | 5,046,414 | $18.4B | 1.38% | |
| 22 | CATBUSDASTRIA THERAPEUTICS INC | 2,457,348 | $13.2B | 0.99% | |
| 23 | CGEMCULLINAN THERAPEUTICS INC | 1,379,965 | $10.4B | 0.78% | |
| 24 | ABVXABIVAX SA | 1,345,780 | $10.3B | 0.77% | |
| 25 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $8.0B | 0.60% | |
| 26 | SEPNSEPTERNA INC | 540,453 | $5.7B | 0.43% | |
| 27 | SRZNSURROZEN INC | 632,931 | $5.7B | 0.42% | |
| 28 | ZURAZURA BIO LTD | 4,631,216 | $4.9B | 0.36% | |
| 29 | ARTVARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $2.4B | 0.18% | |
| 30 | —CASI PHARMACEUTICALS INC | 987,259 | $1.2B | 0.09% | |
| 31 | TENXTENAX THERAPEUTICS INC | 98,564 | $567.7M | 0.04% |